Clinica
Nervomatrix's targeted neurostimulator gets FDA nod
11 January 2011
Madeleine Armstrong
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- St Jude's neuromodulator fails in migraine trial – US approval unlikely?
- Toumaz sets up JV, readies for US launch of wireless patient monitoring "plaster"
- Novartis, J&J offer backing to Atlas Genetics in £16.9m round
- Quarterly results round-up: St Jude and Quest cut jobs to rein in costs, Baxter strong again
Other Informa News
